세계의 신경 모니터링 시스템 시장(2023-2030년)

Overview

Global Nerve Monitoring Systems Market reached US$ 1.4 billion in 2022 and is expected to reach US$ 5.4 billion by 2030, growing with a CAGR of 5.6% during the forecast period 2023-2030.

Intraoperative nerve monitoring (IOM) enables surgeons to monitor and control the function of the nerves during a surgical procedure. When neurosurgery and spinal surgery are required, this entails the use of advanced technology equipment that has become the standard of treatment. Intraoperative nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT and general surgeries.

Furthermore, the global nerve monitoring systems market is driven by various factors like an increase in the cases of nerve-related disorders, a rise in advancements like the inclusion of AI, a rise in product launches by key players, collaboration and acquisition with other companies and others having significant key players like Medtronic, Nuvasive, NihonKohden, CheckPoint Surgicals and others.

Dynamics

Rising Use of Nerve Monitoring in Trauma Cases

The rise in the use of nerve monitoring in trauma cases is one of the key factors that helps the market to grow during the forecast period. The use of intraoperative nerve monitoring (IONM) as an aid in dissection of the scar tissue is believed to minimize the risk of nerve injury. These systems help surgeons to know the functional integrity of nerves and indeed the use of these systems rises in the market.

For instance, in April 2021 Penn Medicine launched the Penn Nerve Center, which unites experts across disciplines to offer expert diagnosis and cutting-edge treatment for a wide range of nerve conditions including traumatic nerve injuries, nerve entrapment, nerve compression, and nerve tumours.

Advancements in Nerve Monitoring Systems

Advancements in Nerve Monitoring Systems are one of the key factors that help the market to grow during the forecast period. These advancements help the surgeons to accurately locate and monitor the nerves which indeed reduces the damage to the patient during the surgical procedures. Several advancements have been integrated into the nerve monitoring systems one of them was Machine learning. The efficiency and reliability of nerve monitoring will be enhanced with the use of ML models. There are various machine learning models like Neural Networks, Artificial Neural Networks, Convolutional Neural Networks and many more.

For instance, in March 2022, Researchers from the Korea Advanced Institute of Science and Technology (KAIST) developed a mind-reading system for decoding neural signals from the brain during arm movement. This system uses electroencephalography (EEG) and electrocorticography (ECoG) techniques.

The ECoG is primarily used to find potential sources of epileptic seizures, meaning the electrodes are placed in different locations for different patients and may not be in the optimal regions of the brain for detecting sensory and movement signals.

To overcome these problems, Professor Jeong's team developed a new method for decoding ECoG neural signals during arm movement. The system is based on a machine-learning system for analyzing and predicting neural signals called an 'echo-state network' and a mathematical probability model called the Gaussian distribution.

Rise In the Product Launches

Rise in the product launches is one of the key factors that helps the market to grow during the forecast period. For instance, in June 2021, NeuraLace Medical, Inc., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today that it has received FDA 510(k) clearance for Axon Therapy to non-invasively stimulate peripheral nerves and provide chronic nerve pain relief.

Strategic Initiatives Such as Partnerships, Expansions, And Acquisitions Will Also Lead to Significant Market Growth.

For instance, in April 2022, Assure Holdings Corp. entered into a group purchasing agreement ("GPO") for intraoperative neuromonitoring services with Conductive. The agreement allows Conductive members, which includes 500 hospitals and surgery centers and more than 50 health systems, to take advantage of special pricing and pre-negotiated terms for Assure's Joint Commission-accredited intraoperative neuromonitoring services.

Limited Awareness About Nerve Monitoring Among Healthcare Professionals

Nerve monitoring devices become more complex, requiring extensive device knowledge. Many new fundamental software is integrated with nerve monitoring devices, but misunderstandings and technical challenges may worsen due to a lack of fundamental understanding of neurophysiological monitoring. More professionals are needed in undeveloped or emerging countries to effectively use these devices.

Segment Analysis

The global nerve monitoring systems market is segmented based on product type, technology, application, end-user and region.

The Neurosurgery Segment From The Application Segment Accounted For Approximately 43.7% of Nerve Monitoring Systems Share

The neurosurgery segment from the application segment accounted for 43.7% and it is expected to be dominated during the forecast period. There is a growing burden of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, Huntington's disease, and motor neuron diseases, among others, in the older population across the world. Thus, this leads to progressive neural dysfunction and toxicities, increasing the demand for effective nerve modulation devices, thereby driving growth in the studied market. Thus, with the increasing geriatric population, the burden of neurological diseases may increase and boost the segment's growth during the forecast period.

For instance, according to Alzheimer's Association updated factsheet 2023 An estimated 6.7 million Americans age 65 and older are living with Alzheimer's dementia in 2023. Seventy-three percent are age 75 or older of the total U.S. population. About 1 in 9 people (10.8%) age 65 and older have Alzheimer's dementia. Hence Due to the increasing burden of Alzheimer's Disease, brain surgeries are expected to increase, creating the need for a nerve monitoring system over time.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to factors like these devices are majorly used in a variety of surgical disciplines, such as otolaryngology, spine surgery, and neurosurgery, FDA Clearance, real-time data from nerve monitoring equipment during surgeries increases surgical accuracy and lowers the chance of nerve injury. As technology is developing, monitoring systems have become more sophisticated and user-friendly, luring healthcare providers to invest in these solutions.

In addition, as these systems are essential for the diagnosis and management of such problems, the rising frequency of chronic neurological disorders, and an ageing population contribute to the revenue growth of the market in this region.

In April 2023, Neuspera Medical, a medical device company developing implantable devices for patients battling chronic illnesses, announced it received U.S. Food and Drug Administration (FDA) clearance for the next-generation Neuspera ultra-miniaturized system. The system is comprised of a micro-implant that delivers neurostimulation therapy through a wireless platform including a wearable transmitter and iPad-based clinician programmer.

Competitive Landscape

The major global players in the market include: Medtronic, Nuvasive, NihonKohden, CheckPoint Surgicals, Natus, Inomed, Magstim, Neurowave Systems, Axontronic, Xavant Technologies and among others.

COVID-19 Impact Analysis

COVID had a substantial impact on the global nerve monitoring systems market during the current pandemic COVID-19 is a newly widespread virus with a high infection rate many individuals have faced heart-related issues and brain which indeed resulted in some surgeries at peak stages hence due to the increased number of patients with limited hospital facilities in many parts of the world. Since need for Non-invasive monitoring of individuals with COVID-19 can help triage by monitoring at-risk persons and assessing the need for invasive monitoring modalities.

By Product Type

• Monitors
• Stimulation Devices
• Nerve Monitoring Electrodes
• Probes

By Technology

• Evoked Potential(EP)
  • Somatosensory Evoked Potential (SSEP)
  • Motor Evoked Potential (MEP)
  • Visual Evoked Potential (VEP)
  • Brainstem Auditory Evoked Potential (BAEP)

• Electromyography (EMG)
• Electroencephalography (EEG)
• Electrocorticography (ECOG)

By Application

• Neurosurgery
• Spine Surgery
• ENT Surgery
• Cardiovascular Applications
• Other Applications

By End User

• Hospitals
• Surgical Centers
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• In March 2021 Neurosign gained FDA clearance for the V4 4-channel and 8-channel nerve monitoring system and it is already being used on patients for nerve identification and preservation in the USA. Dr. Jeffson Chung, a surgeon and Assistant Professor of Otolaryngology, and Director of QI and Safety, at West Virginia University Hospital, recently used the V4 in successful thyroidectomy and facial nerve surgeries. For nerve identification and stimulation, Dr. Chung used the Neurosign Bipolar probe.
• In October 2020 Medtronic plc the global leader in medical technology, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital nerve monitoring system, which enables physicians to identify, confirm, and monitor nerve function to help reduce the risk of nerve damage during head and neck surgery.1 The NIM Vital system uses proprietary technology to provide detailed intraoperative nerve condition data that informs surgical strategy,2 increases operative efficiency and precision,3 and helps protect patients' quality of life.

Why Purchase the Report?

• To visualize the global nerve monitoring systems market segmentation based on product type, technology, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global nerve monitoring systems market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The Global Nerve Monitoring Systems Market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by Application
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Use of Nerve Monitoring in Trauma Cases
    • 4.1.1.2. Advancements in Nerve Monitoring Systems
    • 4.1.1.3. Rise In the Product Launches
    • 4.1.1.4. Strategic Initiatives Such as Partnerships, Expansions, And Acquisitions Will Also Lead To Significant Market Growth
  • 4.1.2. Restraints
    • 4.1.2.1. Limited Awareness About Nerve Monitoring Among Healthcare Professionals
  • 4.1.3. Opportunity
    • 4.1.3.1. Increase in the Cases of Nerve-Related Disorders
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Monitors*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Stimulation Devices
• 7.4. Nerve monitoring Electrodes
• 7.5. Probes

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 8.1.2. Market Attractiveness Index, By Technology
• 8.2. Evoked Potential(EP)*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Electromyography (EMG)
• 8.4. Electroencephalography (EEG)
• 8.5. Electrocorticography (ECOG)

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Neurosurgery *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Spine Surgery
• 9.4. ENT Surgery
• 9.5. Cardiovascular Applications
• 9.6. Other Applications

10. By End User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.1.2. Market Attractiveness Index, By End User
• 10.2. Hospitals *
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Surgical Centers
• 10.4. Ambulatory Surgical Centers
• 10.5. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. UK
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. Australia
    • 11.5.7.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. Medtronic *
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. Nuvasive
• 13.3. NihonKohden
• 13.4. CheckPoint Surgicals
• 13.5. Natus
• 13.6. Inomed
• 13.7. Magstim
• 13.8. Neurowave Systems
• 13.9. Axontronic
• 13.10. Xavant Technologies

LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us